David Cordani - 20 Apr 2022 Form 4 Insider Report for Cigna Corp (CI)

Role: Chairman & CEO, Director
Signature: By: Jill M. Stadelman, attorney-in-fact
Issuer symbol: CI
Transactions as of: 20 Apr 2022
Net transactions value: -$4,821,445
Form type: 4
Filing time: 22 Apr 2022, 17:36:06 UTC
Previous filing: 20 Apr 2022
Next filing: 19 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CI	Common Stock, $.01 Par Value	Options Exercise	$6,407,919	+53,004	+37%	$120.90	198,130	20 Apr 2022	Direct	F1
transaction	CI	Common Stock, $.01 Par Value	Sale	$346,290	-1,300	-0.66%	$266.38	196,830	20 Apr 2022	Direct	F1, F2
transaction	CI	Common Stock, $.01 Par Value	Sale	$1,367,768	-5,155	-2.6%	$265.33	191,675	20 Apr 2022	Direct	F1, F3
transaction	CI	Common Stock, $.01 Par Value	Sale	$2,048,892	-7,650	-4%	$267.83	184,025	20 Apr 2022	Direct	F1, F4
transaction	CI	Common Stock, $.01 Par Value	Sale	$2,353,729	-8,741	-4.7%	$269.27	175,284	20 Apr 2022	Direct	F1, F5
transaction	CI	Common Stock, $.01 Par Value	Sale	$6,049,500	-22,534	-13%	$268.46	152,750	20 Apr 2022	Direct	F1, F6
transaction	CI	Common Stock, $.01 Par Value	Options Exercise	$936,815	+7,749	+5.1%	$120.90	160,499	21 Apr 2022	Direct	F1
holding	CI	Common Stock, $.01 Par Value						1,678	20 Apr 2022	By 401(k)	F7
holding	CI	Common Stock, $.01 Par Value						370,915	20 Apr 2022	By GRAT
holding	CI	Common Stock, $.01 Par Value						39,795	20 Apr 2022	By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CI	Employee Stock Option (Right to Buy)	Options Exercise	$0	-53,004	-47%	$0.000000	60,879	20 Apr 2022	Common Stock, $.01 Par Value	53,004	$120.90	Direct	F1, F8
transaction	CI	Employee Stock Option (Right to Buy)	Options Exercise	$0	-7,749	-13%	$0.000000	53,130	21 Apr 2022	Common Stock, $.01 Par Value	7,749	$120.90	Direct	F1, F8

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2022.
F2	Represents the weighted average price of the shares sold. The prices actually received ranged from $266.00 to $266.98 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
F3	Represents the weighted average price of the shares sold. The prices actually received ranged from $265.00 to $265.97 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
F4	Represents the weighted average price of the shares sold. The prices actually received ranged from $267.07 to $267.99 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
F5	Represents the weighted average price of the shares sold. The prices actually received ranged from $269.00 to $269.68 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
F6	Represents the weighted average price of the shares sold. The prices actually received ranged from $268.00 to $268.99 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
F7	Represents shares acquired through ongoing participation in Cigna's 401(k) Plan.
F8	This option was granted on February 25, 2015. The option vested in three equal annual installments on the first, second and third anniversaries of the grant date.